Status:
COMPLETED
The Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib Vaccine
Lead Sponsor:
Public Health England
Conditions:
Haemophilus Influenzae Type b
Eligibility:
All Genders
9-4 years
Phase:
PHASE4
Brief Summary
To measure the magnitude and persistence of the antibody response to a booster dose of Hib conjugate vaccine given between 9 months and 4 years of age to UK children who had completed primary immunisa...
Eligibility Criteria
Inclusion
- Written informed consent from parent or legal guardian of the infant or child
- Age \>= 9 months and \<4 years at recruitment
- Eligible to receive a single dose of Hib vaccine as per the UK schedule
- Receipt of three doses of Hib vaccine in infancy
Exclusion
- History of Hib infection
- History of severe local reaction that can be confidently related to a prior Hib immunisation
- Deferral of vaccination if acute illness and/or temperature \>38C on day of vaccination
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00197782
Start Date
April 1 2003
End Date
December 1 2005
Last Update
August 24 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.